Novo Nordisk’s $570 billion valuation is more than Denmark’s GDP—but PM isn’t worried about a ‘Nokia risk’
The success of Novo’s weight-loss treatments has transformed the drugmaker into Europe’s most valuable company and made it a key driver of domestic economic growth.
Tomas Kauer - Moderator 
The success of Novo’s weight-loss treatments has transformed the drugmaker into Europe’s most valuable company and made it a key driver of domestic economic growth. Read More
:quality(85):upscale()/2024/09/09/785/n/1922283/901e710666df358b373de2.40207443_.jpg)
:quality(85):upscale()/2024/06/07/726/n/1922283/10bee64e666334778cf548.63095318_.jpg)
